钛系吸附剂
Search documents
碧水源:碧水源旗下华特源的钛系吸附剂适配项目碱性盐湖,对锂的选择性及回收效率较高
Mei Ri Jing Ji Xin Wen· 2025-11-24 06:40
碧水源(300070.SZ)11月24日在投资者互动平台表示,公司通过出售膜设备及吸附剂参与相关项目。 碧水源旗下华特源的钛系吸附剂适配项目碱性盐湖,长期工业化运行中性能较好,对锂的选择性及回收 效率较高。盐湖专用纳滤膜离子分离效果、运行稳定性与使用寿命符合要求。"原卤直接提锂"工艺路径 无需传统盐田晾晒,优化占地、周期与投资,系统稳定且为行业提供可复制模式。 (文章来源:每日经济新闻) 每经AI快讯,有投资者在投资者互动平台提问:最近碳酸锂现货和期货价格不断暴涨,贵公司的盐湖 提锂业务收益如何? ...
碧水源(300070) - 2025年5月8日投资者关系活动记录表
2025-05-08 09:48
Group 1: 2024 Operational Challenges and Responses - In 2024, the company faced significant market downturns and a reduction in external orders, impacting operational performance [2] - The company adjusted its market strategy, enhanced internal incentives, and focused on core business areas to address these challenges [2] - The company achieved a substantial increase in order acquisition, securing 50% of the total 2.2 million tons from the top 10 water treatment projects in the country [2] Group 2: Financial Performance and Investment Losses - The company reported an investment loss of approximately 420 million from its stake in Yunnan Water, which affected overall performance [3] - The subsidiary, Liangye, incurred a loss of about 150 million, further impacting the company's financial results [3] Group 3: Strategic Directions for 2025 - The company plans to restructure its business by integrating renewable energy with seawater desalination and salt chemical industries [4] - It aims to enhance its pharmaceutical sector, having completed pilot tests for various membrane products, with ongoing sales efforts [4] - The company is focusing on lithium extraction from salt lakes, improving the performance and cost-effectiveness of its titanium-based adsorbents [4] Group 4: Operational Improvements and Innovations - The company is advancing the standardization, digitalization, and cost-effectiveness of its water service operations [4] - It is reinforcing its competitive edge in traditional water treatment membrane technologies, achieving significant advancements in efficiency [4] - The company is implementing targeted strategies to boost sales in the industrial membrane sector, capitalizing on opportunities arising from the US-China trade tensions [4] Group 5: Risk Management and Future Outlook - The company anticipates a manageable impact from potential further impairment losses from Yunnan Water, estimated at just over 100 million [6] - The company is committed to improving governance, internal controls, and addressing historical risks in a phased manner [4]